 DEER PARK, Ill., March 17, 2021 GLOBE NEWSWIRE -- Eton Pharmaceuticals, Inc Nasdaq: ETON, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has appointed Jenn Adams to its board of directors effective March 17, 2021. Ms. Adams brings extensive commercial, operational, and leadership experience in the pharmaceutical industry. 